Skip to main content
Shivalik Rasayan Ltd. logo

Shivalik Rasayan Ltd. — Investor Relations & Filings

Ticker · SHIVALIK ISIN · INE788J01021 LEI · 335800FEB4CFANKSV783 BSE.NS Manufacturing
Open in API
Filings indexed 226 across all filing types
Latest filing 2023-11-24 Regulatory Filings
Country IN India
Listing BSE.NS SHIVALIK

About Shivalik Rasayan Ltd.

https://shivalikrasayan.com/

Shivalik Rasayan Ltd. is a diversified chemical and pharmaceutical manufacturer specializing in the production of organophosphorus-based agrochemicals and high-potency active pharmaceutical ingredients (APIs). The company operates through two primary business segments: Agrochemicals and Pharmaceuticals. In the agrochemical sector, it is a leading producer of technical-grade insecticides, including Dimethoate and Malathion. Its pharmaceutical division focuses on the development and manufacture of oncology APIs and finished dosage forms, utilizing advanced research and development capabilities to serve global markets. Shivalik Rasayan maintains state-of-the-art manufacturing facilities designed to meet international regulatory standards, positioning itself as a key supplier of specialized chemical intermediates and complex therapeutic solutions for the healthcare and agricultural industries.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication from Shivalik Rasayan Limited to stock exchanges (BSE and NSE) dated 24.11.2023. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the issuance of duplicate share certificates when original certificates are lost or misplaced. The content details the issuance of duplicate share certificates to a shareholder, including folio number, old and new certificate numbers, and share details. The document is short (2182 characters) and serves as an official intimation or notification to the stock exchanges about a corporate action related to share certificates. It is not a financial report, earnings release, management discussion, or any other detailed report. It is also not a report publication announcement or certification. The closest fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-11-24 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter from Shivalik Rasayan Limited addressed to stock exchanges (BSE and NSE) regarding compliance with Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the issuance of duplicate share certificates due to lost original certificates. The content is a regulatory compliance notification related to share certificate issuance and does not contain financial statements, management discussion, or other report content. The document length is short (2121 characters) and is an announcement of a regulatory compliance event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-11-21 English
Copy of Newspaper Publication
Regulatory Filings
2023-11-11 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement from Shivalik Rasayan Limited informing stock exchanges about receiving a Certificate of Suitability for a product (Temozolomide) from a European regulatory body. It is addressed to BSE and NSE and requests them to take note. There is no financial data, no report attached or referenced, and the document is brief (1562 characters). It is clearly an official regulatory announcement but not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-11-10 English
Change in Management
Regulatory Filings
2023-11-10 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a statement submitted to stock exchanges regarding the deviation or variation in the utilization of funds raised through a preferential issue by Shivalik Rasayan Limited for the quarter ended September 30, 2023. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 32, and includes details about the amount raised, intended use of funds, and confirmation of no deviation by the audit committee. The document is a regulatory compliance filing related to fund utilization and does not contain financial statements or detailed financial performance data. It is not an annual or interim report, earnings release, or audit report. The document is a formal regulatory announcement about fund usage and compliance, fitting the definition of a Regulatory Filing (RNS). The document length is under 5,000 characters and is a statement rather than a full report, reinforcing the classification as RNS rather than a full financial report or capital update.
2023-11-10 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.